- Trials with a EudraCT protocol (31)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
31 result(s) found for: Complex Partial Seizure Disorder AND Seizures.
Displaying page 1 of 2.
EudraCT Number: 2007-005440-25 | Sponsor Protocol Number: SP904 | Start Date*: 2009-02-16 | ||||||||||||||||
Sponsor Name:UCB BIOSCIENCES, Inc. | ||||||||||||||||||
Full Title: A Multicenter, Open-label Extension Trial to Assess the Long-term Use of Lacosamide Monotherapy and Safety of Lacosamide Monotherapy and Adjunctive Therapy in Subjects with Partial-onset Seizures | ||||||||||||||||||
Medical condition: Partial-onset seizures (with and without secondary generalization) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) IE (Completed) ES (Completed) AT (Completed) DK (Completed) PT (Not Authorised) IT (Completed) FR (Completed) DE (Completed) Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-005439-27 | Sponsor Protocol Number: SP902 | Start Date*: 2009-02-16 | ||||||||||||||||
Sponsor Name:UCB BIOSCIENCES, Inc. | ||||||||||||||||||
Full Title: A Historical-controlled, Multicenter, Double-blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400mg/day Monotherapy in Subjects with Partial-onset Seizures | ||||||||||||||||||
Medical condition: Partial-onset seizures (with or without secondary generalization) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) IE (Completed) ES (Completed) AT (Completed) DK (Completed) PT (Not Authorised) IT (Completed) FR (Completed) DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-005344-27 | Sponsor Protocol Number: YKP3089C040 | Start Date*: 2022-02-03 | |||||||||||||||||||||
Sponsor Name:SK Life Science, Inc. | |||||||||||||||||||||||
Full Title: Open-Label Safety and Efficacy Study of Cenobamate (YKP3089) in Pediatric Subjects with Partial-onset (Focal) Seizures | |||||||||||||||||||||||
Medical condition: partial onset (focal) seizures | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Ongoing) HU (Ongoing) PL (Ongoing) ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011181-28 | Sponsor Protocol Number: SP954 | Start Date*: 2009-11-02 | |||||||||||
Sponsor Name:Schwartz Biosciences, INC - UCB Group | |||||||||||||
Full Title: An open-label, multicenter, multinational study of lacosamide as first add-on anti epileptic drug (AED) treatment in subjects with partial onset seizures. ESTUDIO ABIERTO, MULTICÉNTRICO Y MULTINACI... | |||||||||||||
Medical condition: Epilepsy / Epilepsia | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) AT (Completed) FI (Completed) IT (Completed) PL (Ongoing) NL (Prematurely Ended) BG (Completed) FR (Completed) GR (Completed) HU (Completed) PT (Prematurely Ended) DE (Completed) CZ (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020871-22 | Sponsor Protocol Number: AGG-901 | Start Date*: 2011-02-02 | |||||||||||
Sponsor Name:West-ward Pharmaceutical Corporation | |||||||||||||
Full Title: An international, double-blind, parallel-group, placebo-controlled, randomized study: evaluation of the efficacy and safety of phenobarbital as adjunctive therapy in participants (≥ 17 to 70 years ... | |||||||||||||
Medical condition: Epilepsy with partial onset seizures (complex or simple with motor symptoms only) whether or not secondarily generalized. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006168-31 | Sponsor Protocol Number: E2007-G000-305 | Start Date*: 2008-08-28 |
Sponsor Name:Eisai Ltd | ||
Full Title: A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (perampanel) Given as Adjunctive Therapy in Subjects with Refractory Partial S... | ||
Medical condition: Epilepsy: refractory partial seizures with or without secondary generalisation | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) BE (Completed) NL (Completed) DE (Completed) FR (Completed) SE (Completed) GB (Completed) DK (Completed) FI (Completed) IT (Completed) GR (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004334-26 | Sponsor Protocol Number: N01222 | Start Date*: 2015-02-10 | |||||||||||
Sponsor Name:UCB Japan Co. Ltd | |||||||||||||
Full Title: A Multicenter, Open, Long-term Follow-up Study to Evaluate the Safety and Efficacy of L059 (Levetiracetam) at Individual Optimal Dose Ranging From 500 to 3000 mg/Day in Twice Daily Administration i... | |||||||||||||
Medical condition: Epilepsies Partial | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003839-68 | Sponsor Protocol Number: 333369-EPY-3001/3004 | Start Date*: 2006-11-09 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RWJ-333369 as Adjunctive Therapy in Subjects with Partial Onse... | |||||||||||||
Medical condition: Partial Onset Epilepsy Seizures | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) SE (Prematurely Ended) DE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004378-40 | Sponsor Protocol Number: SP0925 | Start Date*: 2015-03-10 | |||||||||||
Sponsor Name:UCB BIOSCIENCES Inc. | |||||||||||||
Full Title: A Multicenter, Open-label Trial to Assess the Safety and Tolerability of a Single Intravenous Loading Dose of Lacosamide Followed by Oral Lacosamide Maintenance as Adjunctive Therapy in Subjects Wi... | |||||||||||||
Medical condition: Partial Epilepsies Partial Onset Seizures | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006169-33 | Sponsor Protocol Number: E2007-G000-306 | Start Date*: 2008-07-17 |
Sponsor Name:Eisai Ltd | ||
Full Title: Estudio doble ciego, controlado con placebo, con aumento gradual de dosis, en grupos paralelos para evaluar la eficacia y la seguridad de E2007 (perampanel) administrado como terapia adyuvante en p... | ||
Medical condition: Epilepsia: crisis parciales refractarias con o sin crisis secundarias generalizadas Epilepsy - refractory partial seizures with or without secondary generalisation | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) CZ (Completed) PT (Completed) HU (Completed) EE (Completed) LT (Completed) PL (Completed) LV (Completed) IT (Completed) BG (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-001458-22 | Sponsor Protocol Number: A0081157 | Start Date*: 2007-07-31 | |||||||||||
Sponsor Name:PFIZER | |||||||||||||
Full Title: "ESTUDIO ALEATORIZADO, DOBLE CIEGO, DE GRUPOS PARALELOS, MULTICÉNTRICO, CON DOSIS FLEXIBLES, COMPARATIVO DE PREGABALINA Y LEVETIRACETAM COMO TRATAMIENTO ADYUVANTE PARA REDUCIR LA FRECUENCIA DE LAS ... | |||||||||||||
Medical condition: Tratamiento adyuvante de las crisis epilépticas parciales, con o sin generalización secundaria. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) GR (Completed) DE (Prematurely Ended) BE (Completed) FR (Completed) CZ (Completed) IT (Completed) LT (Completed) SI (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-007687-41 | Sponsor Protocol Number: CARISEPY3013 | Start Date*: 2009-02-17 | |||||||||||
Sponsor Name:Janssen Cilag International, NV | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Carisbamate as Adjunctive Therapy in Subjects With Partial On... | |||||||||||||
Medical condition: Epilepsy with partial onset seizures | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017961-52 | Sponsor Protocol Number: CBGG492A2207 | Start Date*: 2010-05-06 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A 12-week, multi-center,randomized, double-blind, placebo-controlled efficacy and safety study examining seizure frequency of BGG492 capsules administration orally three times daily (TID) as adjunc... | |||||||||||||
Medical condition: refractory partial-onset seizures | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) IT (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002929-78 | Sponsor Protocol Number: CARISEPY3007- Amendment INT-2/GBR-1 | Start Date*: 2007-11-13 | |||||||||||
Sponsor Name:Ortho-McNeil Janssen Scientific Affairs, LLC | |||||||||||||
Full Title: A Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Retention Rate, Efficacy, Safety, and Tolerability of Carisbamate, Topiramate and Levetiracetam as Adjunctive Therapy i... | |||||||||||||
Medical condition: Partial onset seizures | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) CZ (Prematurely Ended) BE (Temporarily Halted) FI (Completed) FR (Completed) IT (Prematurely Ended) ES (Completed) PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005098-37 | Sponsor Protocol Number: CARISEPY3013/3014 | Start Date*: 2009-01-22 | |||||||||||
Sponsor Name:Janssen Cilag International, NV | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Carisbamate as Adjunctive Therapy in Subjects With Partial On... | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FI (Completed) DE (Completed) SE (Completed) NL (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012587-14 | Sponsor Protocol Number: BIA-2093-401 | Start Date*: 2010-01-14 | |||||||||||
Sponsor Name:BIAL - Portela & Ca, S.A. | |||||||||||||
Full Title: SEGURIDAD Y EFICACIA DEL ACETATO DE ESLICARBAZEPINA (ESL) COMO TERAPIA ADYUVANTE PARA CRISIS PARCIALES EN PACIENTES MAYORES/ SAFETY AND EFFICACY OF ESLICARBAZEPINE ACETATE (ESL) AS ADJUNCTIVE THERA... | |||||||||||||
Medical condition: Terapia adyuvante de crisis parciales en pacientes mayores / Adjunctive therapy of partial-onset seizures in elderly patients | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) CZ (Completed) AT (Completed) PT (Completed) DE (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000144-14 | Sponsor Protocol Number: N01276 | Start Date*: 2008-07-14 | |||||||||||
Sponsor Name:UCB Inc | |||||||||||||
Full Title: An international, double-blind, randomized, multi-center, parallel group, historical-control conversion to monotherapy study to evaluate the efficacy and safety of brivaracetam in subjects (≥ 16 to... | |||||||||||||
Medical condition: Partial onset seizures with or without secondary generalization. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Prematurely Ended) DE (Prematurely Ended) SE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017744-14 | Sponsor Protocol Number: RGB113905 | Start Date*: 2010-07-28 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development Ltd | |||||||||||||
Full Title: An Open-Label, Flexible-Dose Study of Retigabine Immediate Release (IR) as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults with Partial-Onset Seizures. | |||||||||||||
Medical condition: Epilepsy - partial-onset seizures with or without secondary generalisation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Completed) ES (Completed) FR (Completed) BE (Completed) DK (Completed) IT (Completed) BG (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002515-27 | Sponsor Protocol Number: E2090-E044-312 | Start Date*: 2008-02-21 | |||||||||||
Sponsor Name:Eisai Ltd | |||||||||||||
Full Title: A double-blind, randomised, placebo-controlled, multi-centre study to assess the efficacy and safety of adjunctive zonisamide in paediatric partial onset seizures | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) HU (Completed) FR (Completed) LV (Completed) EE (Completed) PL (Completed) IT (Completed) ES (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003771-35 | Sponsor Protocol Number: UX007G-CL201 | Start Date*: 2014-02-11 | |||||||||||
Sponsor Name:Ultragenyx Pharmaceutical Inc | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adaptive Study to Assess the Safety and Efficacy of UX007 in Subjects with Glucose Transporter Type 1 Deficiency Syndrome | |||||||||||||
Medical condition: Glucose Transporter Type 1 deficiency syndrome | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) GB (Completed) FR (Ongoing) HU (Completed) ES (Completed) DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.